The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: A new selection criterion for adjuvant therapy?

HPB

Volumn 13, Issue 9, 2011, Pages 605-611

  Patel, Sameer H ^a   Kooby, David A ^a   Staley Iii, Charles A ^a   Sarmiento, Juan M ^a   Maithel, Shishir K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chemotherapy < hilar cholangiocarcinoma; pathology; resection < intrahepatic cholangiocarcinoma

Indexed keywords

TUMOR MARKER;

ADULT; AGED; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INVASION; CONFERENCE PAPER; CYSTIC DUCT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; REGRESSION ANALYSIS; TUMOR VOLUME;

EID: 80051865003     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00335.x     Document Type: Conference Paper

References (32)

1. Shaib Y, El-Serag HB,. (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24: 115-125. (Pubitemid 38738341)
2. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD,. (2005) Cholangiocarcinoma. Lancet 366: 1303-1314. (Pubitemid 41416587)
3. Malhi H, Gores GJ,. (2006) Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 45: 856-867. (Pubitemid 44646688)
4. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al,. (2008) Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 248: 84-96.
5. Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al,. (2008) Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg 15: 41-54. (Pubitemid 351279840)
6. Chou F, Sheen-Chen S, Chen Y, Chen M, Chen C,. (1997) Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 44: 760-765. (Pubitemid 27281113)
7. Dingle BH, Rumble RB, Brouwers MC,. (2005) The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review. Can J Gastroenterol 19: 711-716. (Pubitemid 43125123)
8. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al,. (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362: 1273-1281.
9. Todoroki T,. (2000) Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 47: 644-649. (Pubitemid 30417267)
10. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al,. (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicentre prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95: 1685-1695.
11. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, et al,. (2011) Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 18: 615-658.
12. Morise Z, Sugioka A, Tokoro T, Tanahashi Y, Okabe Y, Kagawa T, et al,. (2010) Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol 2: 58-64.
13. Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, et al,. (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92: 2374-2383. (Pubitemid 33029082)
14. Farges O, Fuks D, Le Treut YP, Azoulay D, Laurent A, Bachellier P, et al,. (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer 117: 2170-2177.
15. Allen PJ, Reiner AS, Gonen M, Klimstra DK, Blumgart LH, Brennan MF, et al,. (2008) Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. HPB 10: 341-346.
16. Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, et al,. (2001) Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and para-aortic node dissection. Ann Surg 233: 385-392. (Pubitemid 32187818)
17. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al,. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245: 755-762. (Pubitemid 46684105)
18. Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, et al,. (2002) Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 49: 311-316. (Pubitemid 34606541)
19. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al,. (2009) Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 33: 1247-1254.
20. Yubin L, Chihua F, Zhixiang J, Jinrui O, Zixian L, Jianghua Z, et al,. (2008) Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China. Ann Surg Oncol 15: 2113-2119.
21. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, et al,. (2009) Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg 13: 1470-1479.
22. Pawlik TM, Pulitano C, Alexandrescu S, Gamblin TC, Ferrone C, Sotiropoulos G, et al,. Intrahepatic cholangiocarcinoma: an international, multi-institutional analysis of prognostic factors and lymph node assessment. Oral Abstract, Society of Surgical Oncology Meeting, San Antonio, TX, 20-22 January.
23. National Comprehensive Cancer Network (NCCN). (2010) Clinical practice guidelines in oncology: hepatobiliary cancers; V. 2.2010. [Accessed 29 February 2011.
24. Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, et al,. (2010) Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 251: 675-681.
25. Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, et al,. (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16: 14-22.
26. Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, et al,. (2009) Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 15: 5976-5982.
27. Oshiro Y, Sasaki R, Kobayashi A, Murata S, Fukunaga K, Kondo T, et al,. (2011) Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma. Eur J Surg Oncol 37: 60-64.
28. Young AL, Prasad KR, Toogood GJ, Lodge JP,. (2010) Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centres, Leeds. J Hepatobiliary Pancreat Sci 17: 497-504.
29. Weber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH,. (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 193: 384-391. (Pubitemid 32895979)
30. El Rassi ZE, Partensky C, Scoazec JY, Henry L, Lombard-Bohas C, Maddern G,. (1999) Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol 25: 375-380. (Pubitemid 29364223)
31. Ragage F, Debled M, MacGrogan G, Brouste V, Desrousseaux M, Soubeyran I, et al,. (2010) Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer? Cancer 116: 3093-3101.
32. Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, Colburn W, et al,. (2002) Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg 184: 337-340. (Pubitemid 35287354)